Clinical Trial Update: Phase II Study of Avelumab in Patients With Advanced Hepatocellular Carcinoma After Prior Sorafenib Treatment [Phase 2]

View source ↗

Summary

Phase II trial of avelumab in advanced hepatocellular carcinoma after prior sorafenib treatment has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Avelumab (avelumab)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Carcinoma, Hepatocellular | Phase 2 | Status: COMPLETED